Press Releases
Merrion Pharmaceuticals Plc announces commencement of feasibility and option...
Merrion Pharmaceuticals Plc, a publicly listed product development company, announced the commencement of an oral drug delivery feasibility and option agreement with Rebel Pharmaceuticals, LLC,...
Press Releases
Abbott Announces Positive Results from Phase 2 Study of...
Abbott announced positive results from a Phase 2 dose-ranging study of atrasentan, a highly selective endothelin A receptor (ETAR) antagonist in development to help slow...
Press Releases
Reata and Abbott Announce Positive Phase 2b Study Results...
Reata Pharmaceuticals and Abbott announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic kidney disease (CKD), may...
Press Releases
Novartis unveils long-term strategy to grow in a dynamically...
Novartis presented today a strategic overview of the company's diversified healthcare portfolio which creates the potential for future sustainable growth. The company's focused healthcare portfolio...
Press Releases
Pfizer Launches Global Centers for Therapeutic Innovation, a Network...
Pfizer Inc. announced the establishment of the Global Centers for Therapeutic Innovation, an entrepreneurial network of partnerships with leading academic medical centers to...
Press Releases
Pfizer Inc, Study Shows Adding INSPRA to Standard Therapy...
Pfizer Inc. announced results from the EMPHASIS-HF trial(1) showing a statistically significant reduction in risk of cardiovascular (CV) death or heart failure (HF) hospitalization for...
Press Releases
Forest Laboratories Enters Collaboration on Bystolic(R) and Savella(R)
Forest Laboratories, Inc. announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered into a definitive collaboration and distribution agreement for Bystolic(R) (nebivolol)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.